Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
- PMID: 38754982
- DOI: 10.1136/ard-2024-225800
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
Keywords: Arthritis, Psoriatic; Biological Therapy; Therapeutics; Treatment.
Conflict of interest statement
Competing interests: SK is an employee of Mount Sinai and a consultant for AbbVie, Eli Lilly, Janssen and Novartis. She is on the speaker bureau for UCB, Janssen, Lilly, Regeneron and Abbvie. She receives research funding from Abbvie, Pfizer, Incyte and Takeda. MGH has no conflicts of interest to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
